APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune BCG

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immune BCG Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchImmune BCG Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune BCG Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Immune BCG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune BCG Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune BCG Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Immune BCG market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immune BCG is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immune BCG is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immune BCG is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immune BCG is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Immune BCG include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immune BCG, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immune BCG, also provides the sales of main regions and countries. Of the upcoming market potential for Immune BCG, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune BCG sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune BCG market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immune BCG sales, projected growth trends, production technology, application and end-user industry.

Immune BCG Segment by Company

China National Biotec

Sanofi Pasteur

Merck

Serum Institute of India

Japan BCG Lab

Intervax

GSBPL

Immune BCG Segment by Type

2ml Package

1ml Package

0.5ml Package

Other

Immune BCG Segment by Application

Hospital

Clinic

Immune BCG Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune BCG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune BCG and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune BCG.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Immune BCG in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Immune BCG manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune BCG sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune BCG Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2ml Package Major Manufacturers Table 3. 1ml Package Major Manufacturers Table 4. 0.5ml Package Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Immune BCG Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Immune BCG Industry Trends Table 10. Immune BCG Industry Drivers Table 11. Immune BCG Industry Opportunities and Challenges Table 12. Immune BCG Industry Restraints Table 13. Global Immune BCG Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Immune BCG Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Immune BCG Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Immune BCG Revenue Market Share by Region (2021-2026) Table 17. Global Immune BCG Revenue Market Share by Region (2027-2032) Table 18. Global Immune BCG Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Immune BCG Sales by Region (2021-2026) & (k units) Table 20. Global Immune BCG Sales by Region (2027-2032) & (k units) Table 21. Global Immune BCG Sales Market Share by Region (2021-2026) Table 22. Global Immune BCG Sales Market Share by Region (2027-2032) Table 23. Global Immune BCG Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Immune BCG Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Immune BCG Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Immune BCG Sales Market Share by Manufacturers (2021-2026) Table 27. Global Immune BCG Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Immune BCG Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Immune BCG Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Immune BCG Manufacturers, Product Type & Application Table 31. Global Immune BCG Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Immune BCG by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Immune BCG Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Immune BCG Revenue Market Share by Type (2021-2026) Table 38. Global Immune BCG Revenue Market Share by Type (2027-2032) Table 39. Global Immune BCG Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Immune BCG Sales by Type (2021-2026) & (k units) Table 41. Global Immune BCG Sales by Type (2027-2032) & (k units) Table 42. Global Immune BCG Sales Market Share by Type (2021-2026) Table 43. Global Immune BCG Sales Market Share by Type (2027-2032) Table 44. Global Immune BCG Price by Type (2021-2026) & (US$/unit) Table 45. Global Immune BCG Price by Type (2027-2032) & (US$/unit) Table 46. Global Immune BCG Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Immune BCG Revenue Market Share by Application (2021-2026) Table 50. Global Immune BCG Revenue Market Share by Application (2027-2032) Table 51. Global Immune BCG Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Immune BCG Sales by Application (2021-2026) & (k units) Table 53. Global Immune BCG Sales by Application (2027-2032) & (k units) Table 54. Global Immune BCG Sales Market Share by Application (2021-2026) Table 55. Global Immune BCG Sales Market Share by Application (2027-2032) Table 56. Global Immune BCG Price by Application (2021-2026) & (US$/unit) Table 57. Global Immune BCG Price by Application (2027-2032) & (US$/unit) Table 58. China National Biotec Company Information Table 59. China National Biotec Business Overview Table 60. China National Biotec Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. China National Biotec Immune BCG Product Portfolio Table 62. China National Biotec Recent Development Table 63. Sanofi Pasteur Company Information Table 64. Sanofi Pasteur Business Overview Table 65. Sanofi Pasteur Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur Immune BCG Product Portfolio Table 67. Sanofi Pasteur Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck Immune BCG Product Portfolio Table 72. Merck Recent Development Table 73. Serum Institute of India Company Information Table 74. Serum Institute of India Business Overview Table 75. Serum Institute of India Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Serum Institute of India Immune BCG Product Portfolio Table 77. Serum Institute of India Recent Development Table 78. Japan BCG Lab Company Information Table 79. Japan BCG Lab Business Overview Table 80. Japan BCG Lab Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Japan BCG Lab Immune BCG Product Portfolio Table 82. Japan BCG Lab Recent Development Table 83. Intervax Company Information Table 84. Intervax Business Overview Table 85. Intervax Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Intervax Immune BCG Product Portfolio Table 87. Intervax Recent Development Table 88. GSBPL Company Information Table 89. GSBPL Business Overview Table 90. GSBPL Immune BCG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. GSBPL Immune BCG Product Portfolio Table 92. GSBPL Recent Development Table 93. North America Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Immune BCG Sales by Type (2021-2026) & (k units) Table 96. North America Immune BCG Sales by Type (2027-2032) & (k units) Table 97. North America Immune BCG Sales Price by Type (2021-2026) & (US$/unit) Table 98. North America Immune BCG Sales Price by Type (2027-2032) & (US$/unit) Table 99. North America Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Immune BCG Sales by Application (2021-2026) & (k units) Table 102. North America Immune BCG Sales by Application (2027-2032) & (k units) Table 103. North America Immune BCG Sales Price by Application (2021-2026) & (US$/unit) Table 104. North America Immune BCG Sales Price by Application (2027-2032) & (US$/unit) Table 105. North America Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Immune BCG Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Immune BCG Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Immune BCG Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 109. North America Immune BCG Sales by Country (2021-2026) & (k units) Table 110. North America Immune BCG Sales by Country (2027-2032) & (k units) Table 111. North America Immune BCG Sales Price by Country (2021-2026) & (US$/unit) Table 112. North America Immune BCG Sales Price by Country (2027-2032) & (US$/unit) Table 113. United States Immune BCG Revenue (2021-2032) & (US$ Million) Table 114. Canada Immune BCG Revenue (2021-2032) & (US$ Million) Table 115. Mexico Immune BCG Revenue (2021-2032) & (US$ Million) Table 116. Europe Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Immune BCG Sales by Type (2021-2026) & (k units) Table 119. Europe Immune BCG Sales by Type (2027-2032) & (k units) Table 120. Europe Immune BCG Sales Price by Type (2021-2026) & (US$/unit) Table 121. Europe Immune BCG Sales Price by Type (2027-2032) & (US$/unit) Table 122. Europe Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Immune BCG Sales by Application (2021-2026) & (k units) Table 125. Europe Immune BCG Sales by Application (2027-2032) & (k units) Table 126. Europe Immune BCG Sales Price by Application (2021-2026) & (US$/unit) Table 127. Europe Immune BCG Sales Price by Application (2027-2032) & (US$/unit) Table 128. Europe Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Immune BCG Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Immune BCG Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Immune BCG Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. Europe Immune BCG Sales by Country (2021-2026) & (k units) Table 133. Europe Immune BCG Sales by Country (2027-2032) & (k units) Table 134. Europe Immune BCG Sales Price by Country (2021-2026) & (US$/unit) Table 135. Europe Immune BCG Sales Price by Country (2027-2032) & (US$/unit) Table 136. Germany Immune BCG Revenue (2021-2032) & (US$ Million) Table 137. France Immune BCG Revenue (2021-2032) & (US$ Million) Table 138. U.K. Immune BCG Revenue (2021-2032) & (US$ Million) Table 139. Italy Immune BCG Revenue (2021-2032) & (US$ Million) Table 140. Russia Immune BCG Revenue (2021-2032) & (US$ Million) Table 141. Spain Immune BCG Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Immune BCG Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Immune BCG Revenue (2021-2032) & (US$ Million) Table 144. Sweden Immune BCG Revenue (2021-2032) & (US$ Million) Table 145. Poland Immune BCG Revenue (2021-2032) & (US$ Million) Table 146. China Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 147. China Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 148. China Immune BCG Sales by Type (2021-2026) & (k units) Table 149. China Immune BCG Sales by Type (2027-2032) & (k units) Table 150. China Immune BCG Sales Price by Type (2021-2026) & (US$/unit) Table 151. China Immune BCG Sales Price by Type (2027-2032) & (US$/unit) Table 152. China Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 153. China Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 154. China Immune BCG Sales by Application (2021-2026) & (k units) Table 155. China Immune BCG Sales by Application (2027-2032) & (k units) Table 156. China Immune BCG Sales Price by Application (2021-2026) & (US$/unit) Table 157. China Immune BCG Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Immune BCG Sales by Type (2021-2026) & (k units) Table 161. Asia Immune BCG Sales by Type (2027-2032) & (k units) Table 162. Asia Immune BCG Sales Price by Type (2021-2026) & (US$/unit) Table 163. Asia Immune BCG Sales Price by Type (2027-2032) & (US$/unit) Table 164. Asia Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Immune BCG Sales by Application (2021-2026) & (k units) Table 167. Asia Immune BCG Sales by Application (2027-2032) & (k units) Table 168. Asia Immune BCG Sales Price by Application (2021-2026) & (US$/unit) Table 169. Asia Immune BCG Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Immune BCG Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Immune BCG Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Immune BCG Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. Asia Immune BCG Sales by Country (2021-2026) & (k units) Table 175. Asia Immune BCG Sales by Country (2027-2032) & (k units) Table 176. Asia Immune BCG Sales Price by Country (2021-2026) & (US$/unit) Table 177. Asia Immune BCG Sales Price by Country (2027-2032) & (US$/unit) Table 178. Japan Immune BCG Revenue (2021-2032) & (US$ Million) Table 179. South Korea Immune BCG Revenue (2021-2032) & (US$ Million) Table 180. India Immune BCG Revenue (2021-2032) & (US$ Million) Table 181. Australia Immune BCG Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Immune BCG Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Immune BCG Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Immune BCG Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Immune BCG Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Immune BCG Sales by Type (2021-2026) & (k units) Table 187. SAMEA Immune BCG Sales by Type (2027-2032) & (k units) Table 188. SAMEA Immune BCG Sales Price by Type (2021-2026) & (US$/unit) Table 189. SAMEA Immune BCG Sales Price by Type (2027-2032) & (US$/unit) Table 190. SAMEA Immune BCG Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Immune BCG Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Immune BCG Sales by Application (2021-2026) & (k units) Table 193. SAMEA Immune BCG Sales by Application (2027-2032) & (k units) Table 194. SAMEA Immune BCG Sales Price by Application (2021-2026) & (US$/unit) Table 195. SAMEA Immune BCG Sales Price by Application (2027-2032) & (US$/unit) Table 196. SAMEA Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Immune BCG Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Immune BCG Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Immune BCG Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. SAMEA Immune BCG Sales by Country (2021-2026) & (k units) Table 201. SAMEA Immune BCG Sales by Country (2027-2032) & (k units) Table 202. SAMEA Immune BCG Sales Price by Country (2021-2026) & (US$/unit) Table 203. SAMEA Immune BCG Sales Price by Country (2027-2032) & (US$/unit) Table 204. Brazil Immune BCG Revenue (2021-2032) & (US$ Million) Table 205. Argentina Immune BCG Revenue (2021-2032) & (US$ Million) Table 206. Chile Immune BCG Revenue (2021-2032) & (US$ Million) Table 207. Colombia Immune BCG Revenue (2021-2032) & (US$ Million) Table 208. Peru Immune BCG Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Immune BCG Revenue (2021-2032) & (US$ Million) Table 210. Israel Immune BCG Revenue (2021-2032) & (US$ Million) Table 211. UAE Immune BCG Revenue (2021-2032) & (US$ Million) Table 212. Turkey Immune BCG Revenue (2021-2032) & (US$ Million) Table 213. Iran Immune BCG Revenue (2021-2032) & (US$ Million) Table 214. Egypt Immune BCG Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Immune BCG Distributors List Table 218. Immune BCG Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Immune BCG Image Figure 2. Global Immune BCG Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune BCG Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2ml Package Image Figure 5. 1ml Package Image Figure 6. 0.5ml Package Image Figure 7. Other Image Figure 8. Global Immune BCG Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Immune BCG Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Immune BCG Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Immune BCG Revenue (2021-2032) & (US$ Million) Figure 14. Global Immune BCG Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Immune BCG Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Immune BCG Revenue Market Share by Region (2021-2032) Figure 17. Global Immune BCG Sales (2021-2032) & (k units) Figure 18. Global Immune BCG Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Immune BCG Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Immune BCG Sales YoY (2021-2032) & (k units) Figure 21. Europe Immune BCG Sales YoY (2021-2032) & (k units) Figure 22. China Immune BCG Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Immune BCG Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Immune BCG Sales YoY (2021-2032) & (k units) Figure 25. Global Immune BCG Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Immune BCG Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Immune BCG Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Immune BCG Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Immune BCG Revenue Market Share by Type (2021-2032) Figure 31. Global Immune BCG Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Immune BCG Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Immune BCG Sales Market Share by Type (2021-2032) Figure 34. Global Immune BCG Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Immune BCG Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Immune BCG Revenue Market Share by Application (2021-2032) Figure 37. Global Immune BCG Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Immune BCG Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Immune BCG Sales Market Share by Application (2021-2032) Figure 40. North America Immune BCG Revenue Share by Type (2021-2032) Figure 41. North America Immune BCG Sales Share by Type (2021-2032) Figure 42. North America Immune BCG Revenue Share by Application (2021-2032) Figure 43. North America Immune BCG Sales Share by Application (2021-2032) Figure 44. North America Immune BCG Revenue Share by Country (2021-2032) Figure 45. North America Immune BCG Sales Share by Country (2021-2032) Figure 46. Europe Immune BCG Revenue Share by Type (2021-2032) Figure 47. Europe Immune BCG Sales Share by Type (2021-2032) Figure 48. Europe Immune BCG Revenue Share by Application (2021-2032) Figure 49. Europe Immune BCG Sales Share by Application (2021-2032) Figure 50. Europe Immune BCG Revenue Share by Country (2021-2032) Figure 51. Europe Immune BCG Sales Share by Country (2021-2032) Figure 52. China Immune BCG Revenue Share by Type (2021-2032) Figure 53. China Immune BCG Sales Share by Type (2021-2032) Figure 54. China Immune BCG Revenue Share by Application (2021-2032) Figure 55. China Immune BCG Sales Share by Application (2021-2032) Figure 56. Asia Immune BCG Revenue Share by Type (2021-2032) Figure 57. Asia Immune BCG Sales Share by Type (2021-2032) Figure 58. Asia Immune BCG Revenue Share by Application (2021-2032) Figure 59. Asia Immune BCG Sales Share by Application (2021-2032) Figure 60. Asia Immune BCG Revenue Share by Country (2021-2032) Figure 61. Asia Immune BCG Sales Share by Country (2021-2032) Figure 62. SAMEA Immune BCG Revenue Share by Type (2021-2032) Figure 63. SAMEA Immune BCG Sales Share by Type (2021-2032) Figure 64. SAMEA Immune BCG Revenue Share by Application (2021-2032) Figure 65. SAMEA Immune BCG Sales Share by Application (2021-2032) Figure 66. SAMEA Immune BCG Revenue Share by Country (2021-2032) Figure 67. SAMEA Immune BCG Sales Share by Country (2021-2032) Figure 68. Immune BCG Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Immune BCG Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml Package
  • 1ml Package
  • 0.5ml Package
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • China National Biotec
  • Sanofi Pasteur
  • Merck
  • Serum Institute of India
  • Japan BCG Lab
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immune BCG Market by Type
  3. 1.2.1 Global Immune BCG Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2ml Package
  5. 1.2.3 1ml Package
  6. 1.2.4 0.5ml Package
  7. 1.2.5 Other
  8. 1.3 Immune BCG Market by Application
  9. 1.3.1 Global Immune BCG Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Immune BCG Market Dynamics
  1. 2.1 Immune BCG Industry Trends
  2. 2.2 Immune BCG Industry Drivers
  3. 2.3 Immune BCG Industry Opportunities and Challenges
  4. 2.4 Immune BCG Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Immune BCG Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Immune BCG Revenue by Region
  3. 3.2.1 Global Immune BCG Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immune BCG Revenue by Region (2021-2026)
  5. 3.2.3 Global Immune BCG Revenue by Region (2027-2032)
  6. 3.2.4 Global Immune BCG Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Immune BCG Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Immune BCG Sales by Region
  9. 3.4.1 Global Immune BCG Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Immune BCG Sales by Region (2021-2026)
  11. 3.4.3 Global Immune BCG Sales by Region (2027-2032)
  12. 3.4.4 Global Immune BCG Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Immune BCG Revenue by Manufacturers
  2. 4.1.1 Global Immune BCG Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Immune BCG Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Immune BCG Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immune BCG Sales by Manufacturers
  6. 4.2.1 Global Immune BCG Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Immune BCG Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Immune BCG Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Immune BCG Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Immune BCG Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Immune BCG Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Immune BCG Manufacturers, Product Type & Application
  13. 4.7 Global Immune BCG Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Immune BCG Market CR5 and HHI
  16. 4.8.2 2025 Immune BCG Tier 1, Tier 2, and Tier 3
5 Immune BCG Market by Type
  1. 5.1 Global Immune BCG Revenue by Type
  2. 5.1.1 Global Immune BCG Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Immune BCG Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Immune BCG Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Immune BCG Sales by Type
  6. 5.2.1 Global Immune BCG Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immune BCG Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Immune BCG Sales Market Share by Type (2021-2032)
  9. 5.3 Global Immune BCG Price by Type
6 Immune BCG Market by Application
  1. 6.1 Global Immune BCG Revenue by Application
  2. 6.1.1 Global Immune BCG Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Immune BCG Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Immune BCG Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Immune BCG Sales by Application
  6. 6.2.1 Global Immune BCG Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Immune BCG Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Immune BCG Sales Market Share by Application (2021-2032)
  9. 6.3 Global Immune BCG Price by Application
7 Company Profiles
  1. 7.1 China National Biotec
  2. 7.1.1 China National Biotec Company Information
  3. 7.1.2 China National Biotec Business Overview
  4. 7.1.3 China National Biotec Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China National Biotec Immune BCG Product Portfolio
  6. 7.1.5 China National Biotec Recent Developments
  7. 7.2 Sanofi Pasteur
  8. 7.2.1 Sanofi Pasteur Company Information
  9. 7.2.2 Sanofi Pasteur Business Overview
  10. 7.2.3 Sanofi Pasteur Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pasteur Immune BCG Product Portfolio
  12. 7.2.5 Sanofi Pasteur Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Immune BCG Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Serum Institute of India
  20. 7.4.1 Serum Institute of India Company Information
  21. 7.4.2 Serum Institute of India Business Overview
  22. 7.4.3 Serum Institute of India Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute of India Immune BCG Product Portfolio
  24. 7.4.5 Serum Institute of India Recent Developments
  25. 7.5 Japan BCG Lab
  26. 7.5.1 Japan BCG Lab Company Information
  27. 7.5.2 Japan BCG Lab Business Overview
  28. 7.5.3 Japan BCG Lab Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Japan BCG Lab Immune BCG Product Portfolio
  30. 7.5.5 Japan BCG Lab Recent Developments
  31. 7.6 Intervax
  32. 7.6.1 Intervax Company Information
  33. 7.6.2 Intervax Business Overview
  34. 7.6.3 Intervax Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intervax Immune BCG Product Portfolio
  36. 7.6.5 Intervax Recent Developments
  37. 7.7 GSBPL
  38. 7.7.1 GSBPL Company Information
  39. 7.7.2 GSBPL Business Overview
  40. 7.7.3 GSBPL Immune BCG Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GSBPL Immune BCG Product Portfolio
  42. 7.7.5 GSBPL Recent Developments
8 North America
  1. 8.1 North America Immune BCG Market Size by Type
  2. 8.1.1 North America Immune BCG Revenue by Type (2021-2032)
  3. 8.1.2 North America Immune BCG Sales by Type (2021-2032)
  4. 8.1.3 North America Immune BCG Price by Type (2021-2032)
  5. 8.2 North America Immune BCG Market Size by Application
  6. 8.2.1 North America Immune BCG Revenue by Application (2021-2032)
  7. 8.2.2 North America Immune BCG Sales by Application (2021-2032)
  8. 8.2.3 North America Immune BCG Price by Application (2021-2032)
  9. 8.3 North America Immune BCG Market Size by Country
  10. 8.3.1 North America Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Immune BCG Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Immune BCG Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Immune BCG Market Size by Type
  2. 9.1.1 Europe Immune BCG Revenue by Type (2021-2032)
  3. 9.1.2 Europe Immune BCG Sales by Type (2021-2032)
  4. 9.1.3 Europe Immune BCG Price by Type (2021-2032)
  5. 9.2 Europe Immune BCG Market Size by Application
  6. 9.2.1 Europe Immune BCG Revenue by Application (2021-2032)
  7. 9.2.2 Europe Immune BCG Sales by Application (2021-2032)
  8. 9.2.3 Europe Immune BCG Price by Application (2021-2032)
  9. 9.3 Europe Immune BCG Market Size by Country
  10. 9.3.1 Europe Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Immune BCG Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Immune BCG Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Immune BCG Market Size by Type
  2. 10.1.1 China Immune BCG Revenue by Type (2021-2032)
  3. 10.1.2 China Immune BCG Sales by Type (2021-2032)
  4. 10.1.3 China Immune BCG Price by Type (2021-2032)
  5. 10.2 China Immune BCG Market Size by Application
  6. 10.2.1 China Immune BCG Revenue by Application (2021-2032)
  7. 10.2.2 China Immune BCG Sales by Application (2021-2032)
  8. 10.2.3 China Immune BCG Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immune BCG Market Size by Type
  2. 11.1.1 Asia Immune BCG Revenue by Type (2021-2032)
  3. 11.1.2 Asia Immune BCG Sales by Type (2021-2032)
  4. 11.1.3 Asia Immune BCG Price by Type (2021-2032)
  5. 11.2 Asia Immune BCG Market Size by Application
  6. 11.2.1 Asia Immune BCG Revenue by Application (2021-2032)
  7. 11.2.2 Asia Immune BCG Sales by Application (2021-2032)
  8. 11.2.3 Asia Immune BCG Price by Application (2021-2032)
  9. 11.3 Asia Immune BCG Market Size by Country
  10. 11.3.1 Asia Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Immune BCG Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Immune BCG Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immune BCG Market Size by Type
  2. 12.1.1 SAMEA Immune BCG Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Immune BCG Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Immune BCG Price by Type (2021-2032)
  5. 12.2 SAMEA Immune BCG Market Size by Application
  6. 12.2.1 SAMEA Immune BCG Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Immune BCG Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Immune BCG Price by Application (2021-2032)
  9. 12.3 SAMEA Immune BCG Market Size by Country
  10. 12.3.1 SAMEA Immune BCG Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Immune BCG Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Immune BCG Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Immune BCG Value Chain Analysis
  2. 13.1.1 Immune BCG Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Immune BCG Production Mode & Process
  6. 13.2 Immune BCG Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Immune BCG Distributors
  9. 13.2.3 Immune BCG Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst